what is the best way to track surgical complications? jacques x. zhang, b.sc. diana song, md julie...
TRANSCRIPT
What is the Best Way to Track Surgical Complications?
Jacques X. Zhang, B.Sc.Diana Song, MDJulie Bedford, RN, MSNDouglas J. Courtemanche, MD, MS, FRCSC Marija Bucevska, MDJugpal S. Arneja, MD, MBA, FAAP, FACS, FRCSC
Comparing ACS NSQIP versus Traditional M&M Rounds
2
Conflicts of Interests
• Dr. Courtemanche is a director and shareholder with Resilience Software, which made T-Res
• T-Res is used to collect data for M&M Rounds at UBC and the database provided some of the data for the research
What is M&M and NSQIP-P?
3
M&M rounds ACS NSQIP Pediatrics
What is it? Rounds to discuss medical complications and deaths
Discussions are protected under Section 51 of the Evidence Act.1
- Standardized- Tracks post-op complications- Subset of surgical patients - Allows risk-adjustedbenchmarking between hospitals.2-4
Background
1. bclaws.ca2. Khuri SF. 2005;138(5):837-43. 3. Khuri SF, Daley J, Henderson W, et al. 1998;228(October):491-507.4. Ingraham AM, Richards KE, Hall BL, Ko CY. Adv Surg. 2010;44(1):251-267. .
How does it work? Complications are entered
retrospectively into a database.
Some discussed at rounds.
Next Slide…
• NSQIP-P definitions are very strict
4
How NSQIP-P Works
Khuri SF. 2005;138(5):837-43. Khuri SF, Daley J, Henderson W, et al. 1998;228(October):491-507.Ingraham AM, Richards KE, Hall BL, Ko CY. Adv Surg. 2010;44(1):251-267. .
Background
5
M&M rounds ACS NSQIP Pediatrics1-3
Rounds are biweekly or quarterly as organized by the department
Risk-adjusted feedback is provided on a semi-annual basis in the form of a odds ratio for the hospital/department
Used for decades NSQIP P pilot in 2008, BCCH joined in 2011
Surgeon is reviewer Surgical Clinical Reviewer (NSQIP) is reviewer
Looks at all cases Looks at a subset of all cases through rigorous sampling
Cases reviewed quarterly (90 days) Tracks post-op occurrences up to a set 30 days
Complication reported only if surgeon aware Active tracking of patient 30 days post-op
All relevant complications tracked Only NSQIP complications are tracked
Recall and reporting bias Follows strict NSQIP guidelines and definitions
Not risk adjusted Risk-adjusted, allows benchmarking
Low inter-rater reliability High inter-rater reliability4
Low cost and labour High cost ($200,000/yr at BCCH) +labour (2 SCRs/ 2 surgeons champions)
Side-by-Side Comparison
1. Khuri SF. 2005;138(5):837-43. 2. Khuri SF, Daley J, Henderson W, et al. 1998;228(October):491-507.3. Ingraham AM, Richards KE, Hall BL, Ko CY. Adv Surg. 2010;44(1):251-267. .4. Shiloach M, Frencher SK, Steeger JE, et al. J Am Coll Surg. 2010;210(1):6-16
Background
Why this paper?
• Limited studies on:– Pediatric NSQIP in general – Pediatric M&M vs NSQIP– Plastic surgery specific data
• PURPOSE:– To determine the best way to track pediatric
plastic surgeries by comparing complications tracked by NSQIP-P vs traditional M&M rounds, in 2012-2013
6
Purpose
Methods
• For the first 2 full years (2012 and 2013) of NSQIP data: – Extract complications (numerators) for both M&M and
NSQIP– Extract total cases (denominators)
• NSQIP is a subset of M&M – Go through op logs and classify M&M data into “NSQIP
categories” eligible vs ineligible• Stratify data into major and minor complications
7
2012 2013 2012 + 20130
1
2
3
4
5
6
7
8
9
5.48
7.69
6.626.45.79
6.11
Raw Complication Occurrence Rate of NSQIP vs M&M
NSQIPM&M
Com
plic
ation
Rat
e (%
)NSQIP and M&M have similar
rates
8
… However, M&M data includes cases that NSQIP potentially excludes … Need to remove the M&M data that is NSQIP ineligible
NS - Not statistically significant (2-sample Z test)
Results
NSQIP vs M&M: adjusted rates
2012 + 20130
1
2
3
4
5
6
7
8
6.62
6.115.71
Apples vs Apples: NSQIP vs M&M (NSQIP eligible)
NSQIPM&M rawM&M (NSQIP eligible)
Com
plic
ation
Rat
e (%
)
10
NS - Not statistically significant (2-sample Z test)
Results
11
~50% of all cases are not tracked by NSQIP!
Half of all cases are not tracked by NSQIP!
n= 648or (51.4% of all cases)
n=613or (48.6% or all cases)
Results
What is the concordance and discordance rate?
2012 + 2013 M&M+ M&M-NSQIP + 13 27 40NSQIP - 24 584 608subtotal 37 611 648
NSQIP ineligible 40 573 61377 1184 1261
12
Concordance rate for M&M Eligible = 13/37 = 35.1% Concordance rate for NSQIP = 13/40 = 32.5% Discordance rate for M&M = 64/77 = 83.1% (MM+, NSQIP-)Discordance rate for NSQIP = 27/40 = 67.5% (MM-, NSQIP+)
6
2
1
2
2
Types of Occurrence: Patients in both NSQIP and TRES M&M
DehiscenceHematomaDehiscence + Infec-tionBleedingComplex (multiple complications)
Results
What is the discordance rate between NSQIP and M&M?
NSQIP inelig
ible
Eligible but n
ot sampled
Sampled but not a
NSQIP complica
tion
Sampled but complica
tion > 30 days
M&M caught s
omething that N
SQIP miss
ed05
1015202530354045
40
615
3 0
2012-2013 MM+ NSQIP- n=64
Num
ber o
f Cas
es
13
Discordance rate for M&M = 64/77 = 83.1%
Results
What is the discordance rate between NSQIP and M&M?
Documented, not reported Unaware Not a plastics complication0
2
4
6
8
10
12
14
16
18
16
9
2
2012-2013 MM- NSQIP+ n=27
Num
ber o
f Cas
es
14
Discordance rate for NSQIP = 27/40 = 67.5%
Results
NSQIP and M&M track different complications
Infection*
Dehiscence
*
Pneumonia*
Urinary*
Transfusio
n*
Other Resp
iratory
Seroma/H
ematoma
Graft / Pro
sthesis
/ Flap Failu
re
Device Failu
re
Delayed Healing
Scars
Death / Morta
lity*
Other0
0.5
1
1.5
2
2.5
3
3.5
Types of Occurrences
NSQIPM&M
Com
plic
ation
Rat
e (%
)
15
* = NSQIP tracked complication
Results
What about the severity of the complication?
• Stratified into major vs. minor complication– Major complication that leads to:
• Death• Readmission• Re-operation
– Minor complication • Anything else
– Results: we find ~50/50 split in both systems• 85% “Major” for matched complications (MM+ NSQIP+)
16
Results
7 major complications (2012-2013) missed by M&M
Match to M&M Documented, not reported
Unaware Not a plastics complication
0
2
4
6
8
10
12
14
16
18
2
97
2
11
7
2
0
2012-2013 MM- NSQIP+ n=27
Major complicationMinor complication
Num
ber o
f Cas
es
17
Results
Best way to track pediatric plastics complications?
A combination of both M&M rounds and NSQIP…
• NSQIP and M&M have similar
occurrence rates but each has their benefits over the other. NSQIP provides the strict rate of morbidity whereas M&M provides the description.
18
Discussion
MOH
Hospital
Department
Division
Surgeons
NSQIP
M&M
Feedback and Purpose:
19
M&M rounds ACS NSQIP Pediatrics1-3
Rounds are biweekly or quarterly as organized by the department
Risk-adjusted feedback is provided on a semi-annual basis in the form of a odds ratio for the hospital/department
Used for decades NSQIP P pilot in 2008, BCCH joined in 2011
Surgeon is reviewer SCR (nurse) is reviewer
Looks at all cases Looks at a subset of all cases through rigorous sampling
Cases reviewed quarterly (90 days) Tracks post-op occurrences up to a set 30 days
Complication reported only if surgeon aware Active tracking of patient 30 days post-op
All relevant complications tracked Only NSQIP complications are tracked
Recall and reporting bias Follows strict NSQIP guidelines and definitions
Not risk adjusted Risk-adjusted, allows benchmarking
Low inter-rater reliability High inter-rater reliability4
Low cost and labour High cost ($200,000/yr at BCCH) +labour (2 SCRs/ 2 surgeons champions)
Side-by-Side Comparison
1. Khuri SF. 2005;138(5):837-43. 2. Khuri SF, Daley J, Henderson W, et al. 1998;228(October):491-507.3. Ingraham AM, Richards KE, Hall BL, Ko CY. Adv Surg. 2010;44(1):251-267. .4. Shiloach M, Frencher SK, Steeger JE, et al. J Am Coll Surg. 2010;210(1):6-16
Conclusions
20
Conclusion
1. NSQIP misses 50% of cases2. Not all complications are tracked3. NSQIP overall rate is accurate compared to
M&M4. NSQIP methods are strictly defined and
rigorous while M&M is subject to recall and reporting bias
We suggest expansion of NSQIP-P to include currently excluded cases and an extension of the NSQIP-P study interval.
21
Limitations
• Limited to the plastic surgery department at a single institution, and only for a 2-year study period
• Rates for the M&M complications might be artificially under-reported due to the errors in M&M data
• Low number of complications combined with a large variety of plastic procedures may increase the variability in rate
Acknowledgements
Dr. ArnejaDr. CourtemancheDr. Diana SongMarija BucevskaJulie BedfordThe plastics team
23
ADDITIONAL SLIDES
What is the Best Way to Track Plastic Surgery Outcomes: Comparing ACS NSQIP vs M&M rounds
24
QA timeline
1894
1907
1911
1935
1940s
1991
1994
1999
2001
2004
2008
2010
2011
Codman develops anesthesia record Codman helps create the ACS End-Result Concept into practice Anesthesia Mortality Committee
Becomes the Anesthesia Study Commission (Prelude to M&Ms) 2000: T-res
NSQIP Peds at BCCH NSQIP Peds to 40 hospitals
NSQIP Peds initiation (4 hospitals) NSQIP becomes open subscription program
VA, ACS Patient Safety in Surgery Study, 14 large non-VA academic hospitals
VA study PSI at 3 academic non-VA surgical dptNSQIP established in all 132 major VA surgical centers
NSQIP inception in 44 VA hospitals in the NVASRS
However, complication rates are still similar
2012 + 20130
1
2
3
4
5
6
7
8
6.62 6.53
NSQIP vs M&M (NSQIP ineligible)
NSQIP M&M (NSQIP ineligible)
Com
plic
ation
Rat
e (%
)
25
NS - Not statistically significant (2-sample Z test)
Results
NSQIP and M&M obtain similar severity of complications
NSQ
IP
M&
M ra
w
M&
M (N
SQIP
elig
ible
)
M&
M (N
SQIP
inel
igib
le)
2012+2013
01234567
3.31 3.33 2.93 3.26
3.31 2.78 2.783.26
Major vs Minor Complications
majorminor
Com
plic
ation
Rat
e (%
)
26
NS - Not statistically significant (2-sample Z test)
Results
Matched cases are mostly major complications
05
1015202530354045
2
20
313
1 011
20
3
2
2 0
2012-2013 MM+ NSQIP- n=64
Major complicationMinor complication
Num
ber o
f Cas
es
27
Results
28
NSQIP and M&M serve different purposes…
• NSQIP-P returns a hospital and department odds ratio (hospital wide view)
• Whereas M&M returns a divisional and surgeon level rate (patient level view)
MOH
Hospital
Department
Division
Surgeons
NSQIP
M&M
Discussion
Theoretically: Reality: Feedback and Purpose:
All cases All cases
M&MNSQIP
Conclusions
• Similar rates, however:1. NSQIP misses 50% of all cases.2. NSQIP morbidity rate is confirmed against M&M,
even for NSQIP ineligible cases, as well as severity of complications. Validation of the program.
3. Differences in definitions and subjectivity in M&M led to low concordance rate, with NSQIP being a more rigorous system.
4. We suggest expansion of ACS-NSQIP to include currently excluded cases and an extension of the ACS-NSQIP study interval.
29